Elotuzumab progression-free survival data from Phase 2 study of patients with previously-treated multiple myeloma presented at 54th ASH Annual Meeting
9 December 2012 | By Bristol-Myers Squibb Company
Results from Phase 2 open-label study...
List view / Grid view
Abbott Laboratories is an American worldwide healthcare company. With headquarters in Lake Bluff, Illinois, it has 94,000 employees and operates in more than 150 countries.
The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it eventually grew to also sell research-based drugs, medical devices, diagnostics, and nutritional products. It split off the research-based pharmaceuticals into Abbvie in 2013. In 2015, revenues were $20.4 billion.
Abbott has a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products. The company’s in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. In 1985, the company developed the first HIV blood-screening test.
9 December 2012 | By Bristol-Myers Squibb Company
Results from Phase 2 open-label study...
7 December 2012 | By Abbott
Abbott expects to complete separation of AbbVie on Jan. 1, 2013...
28 November 2012 | By Abbott
Abbott board of directors approved the separation of its research-based pharmaceuticals business...
27 November 2012 | By Abbott
Abbott announced that the European Commission has approved HUMIRA®...
13 November 2012 | By Abbott
Details on its phase 3 hepatitis C registrational program...
12 November 2012 | By Abbott
Results from a post-hoc analysis...
12 November 2012 | By Abbott
The first long-term patient-reported health outcomes data...
2 November 2012 | By Abbott
Abbott and its foundation are providing $1 million in funding and product donations...
30 October 2012 | By Abbott
Ensure Complete combines muscle, heart, immune system and bone benefits in one simple shake...
24 October 2012 | By Abbott
ALK test now available in Europe...
24 October 2012 | By Abbott
"These data suggest that adalimumab-treated patients were able to reduce steroid usage..."
23 October 2012 | By Abbott
Results from a post-hoc sub-analysis...
22 October 2012 | By Abbott
Results from an analysis of three-year long-term data...
19 October 2012 | By Abbott
The CHMP has adopted a positive opinion for HUMIRA®...
15 October 2012 | By Abbott
Initial results from "Aviator"...